tecentriq - Cancer Immunotherapy Treatment for NSCLC, ES-SCLC, …
Do not breastfeed during treatment and for at least 5 months after the last dose of TECENTRIQ. Tell your healthcare provider about all the medicines you take, including prescription and over …
Extensive-Stage Small Cell Lung Cancer Treatment - tecentriq
Find out about TECENTRIQ® (atezolizumab) for the treatment of extensive-stage small cell lung cancer (ES-SCLC). See full safety for more information.
Metastatic NSCLC Treatment | TECENTRIQ® (atezolizumab)
Find out about TECENTRIQ® (atezolizumab) for the treatment of metastatic non-small cell lung cancer (NSCLC). See full safety for more information.
How TECENTRIQ® May Work for SCLC | TECENTRIQ® …
Discover how TECENTRIQ® (atezolizumab) immunotherapy helps fight extensive-stage small cell lung cancer (ES-SCLC). See full safety for more information.
How TECENTRIQ® (atezolizumab) May Work for mNSCLC
Learn how TECENTRIQ® (atezolizumab) treatment may work for metastatic non-small cell lung cancer (mNSCLC). See full safety for more information.
Liver Cancer (HCC) Treatment | TECENTRIQ® (atezolizumab)
Find information about liver cancer treatment with TECENTRIQ® (atezolizumab) & Avastin® (bevacizumab). A treatment option for hepatocellular carcinoma (HCC). See full safety for …
PD-L1+ Non-Small Cell Lung Cancer After Surgery - tecentriq
Find out about TECENTRIQ® (atezolizumab) for the treatment of PD-L1+ non-small cell lung cancer after surgery + chemo. See full safety for more information.
Treatment for NSCLC | TECENTRIQ® (atezolizumab)
Learn about the TECENTRIQ® (atezolizumab) treatment process for PD-L1+ non-small cell lung cancer after surgery + chemo. See full safety for more information.
Infusion Treatment for mNSCLC | TECENTRIQ® (atezolizumab)
Learn about the TECENTRIQ® (atezolizumab) infusion treatment process for metastatic non-small cell lung cancer (mNSCLC). See full safety for more information.
Advanced Melanoma Treatment | TECENTRIQ® (atezolizumab)
Learn about TECENTRIQ® (atezolizumab) with COTELLIC® (cobimetinib) & ZELBORAF® (vemurafenib), an immunotherapy combination treatment that works together to treat …